نتایج جستجو برای: cmv

تعداد نتایج: 8052  

Journal: :Chest 2000
G C Riise R Andersson T Bergström A Lundmark F N Nilsson S Olofsson

STUDY OBJECTIVES Cytomegalovirus (CMV) infection is common in patients receiving solid organ transplants, and it is associated with increased morbidity as well as risk for development of chronic rejection. A rapid and sensitive diagnostic method would improve the therapeutic management of CMV infection, including the monitoring of treatment effects. We investigated whether longitudinal determin...

Journal: :Infection and immunity 1980
J Schirm H W Roenhorst T H The

In vitro lymphocyte reactivity (LR) to cytomegalovirus (CMV)-infected human fetal fibroblasts (CMVFF) and cell-free CMV were measured by using lymphocytes from healthy donors. Lymphocytes from all seropositive donors were stimulated by CMVFF, whereas lymphocytes from negative donors were not. The optimal stimulator cell-to-lymphocyte ratio was in the range of 1:5 to 1:50, dependent on the virus...

2017
Hsin-Chen Lin Shao-Min Han Wen-Li Hwang Cheng-Wei Chou Kuang-Hsi Chang Zhi-Yuan Shi Chieh-Lin Jerry Teng

OBJECTIVE Although Cytomegalovirus (CMV) infection is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT), the risk factors for CMV reactivation and treatment failure in CMV endemic areas have remained unclear. This study investigated the risk factors for CMV reactivation among allo-HSCT recipients in an area where CMV is highly endemic. MATERIALS AND MET...

Journal: :Blood 2010
Arne N Akbar

In this issue of Blood, Pourgheysari and colleagues demonstrate that there is a highly exaggerated expansion of CMV-specific CD4 T cells in CMV-seropositive compared with CMV-seronegative CLL patients, particularly after chemotherapy.1 Despite this, patient survival is reduced by almost 4 years in the CMV cohort. However, as CMV CLL individuals do not exhibit symptoms of CMV-induced disease, th...

Journal: :JAMA 1999
S M Whitcup E Fortin A S Lindblad P Griffiths J A Metcalf M R Robinson J Manischewitz B Baird C Perry I M Kidd T Vrabec R T Davey J Falloon R E Walker J A Kovacs H C Lane R B Nussenblatt J Smith H Masur M A Polis

CONTEXT Persons with cytomegalovirus (CMV) retinitis and acquired immunodeficiency syndrome (AIDS) have required lifelong anti-CMV therapy to prevent the progression of retinal disease and subsequent loss of vision. OBJECTIVE To determine whether patients who were taking highly active antiretroviral therapy (HAART) and who had stable CMV retinitis could safely discontinue anti-CMV therapy wit...

Journal: :Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 1984
J Carstens H K Andersen E Spencer M Madsen

We have retrospectively analyzed the incidence of cytomegalovirus (CMV) infection in 250 consecutive renal allograft transplants performed in 244 recipients. The mean follow-up was 35.1+/-25.4 months. Immunosuppression was cyclosporine- or tacrolimus-based triple therapy. CMV infection prophylaxis with ganciclovir for 3 months post transplant was prescribed in CMV-seronegative recipients of all...

2015
Inger Johansson Rune Andersson Vanda Friman Nedim Selimovic Lars Hanzen Salmir Nasic Ulla Nyström Vilborg Sigurdardottir

BACKGROUND Cytomegalovirus (CMV) is associated with an increased risk of cardiac allograft vasculopathy (CAV), the major limiting factor for long-term survival after heart transplantation (HTx). The purpose of this study was to evaluate the impact of CMV infection during long-term follow-up after HTx. METHODS A retrospective, single-centre study analyzed 226 HTx recipients (mean age 45 ± 13 y...

Journal: :Transplantation 2011
Peter A Andrews Vincent C Emery Chas Newstead

The third edition of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease after Solid Organ Transplantation was published in March 2011. This article summarizes the important changes and advances in management in this rapidly evolving field. The pros and cons of universal, or targeted anti-cytomegalovirus (CMV) prophylaxis, and pre-emptive anti-CMV the...

Journal: :Journal of Immunology 2023

Abstract Cytomegalovirus (CMV) is a top priority in vaccine development due to the high burden of disease immunocompromised populations and congenitally infected infants. Evidence suggests that CMV-specific Fc-mediated antibody effector responses, such as dependent cellular phagocytosis cytotoxicity, are key for prevention multiple CMV outcomes. However, human expresses three Fcγ receptors have...

Journal: :The Tohoku journal of experimental medicine 2006
Yasushi Onishi Shin-Ichiro Mori Akiko Higuchi Sung-Won Kim Takahiro Fukuda Yuji Heike Ryuji Tanosaki Toshio Minematsu Yoichi Takaue Takeshi Sasaki Koh Furuta

Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Therefore, preemptive ganciclovir therapy based on early detection of CMV reactivation is widely used to prevent CMV disease. Real-time polymerase chain reaction (PCR) has been widely used for monitoring CMV reactivation as well as the antigenemia assay that...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید